Showing 36 out of 59 results
Herbert Smith Freehills Advises Abcam on acquisition of Expedeon's proteomics and immunology business
Leading global law firm Herbert Smith Freehills is advising Abcam on its acquisition of Expedeon AG's proteomics and immunology business. The transaction …
HERBERT SMITH FREEHILLS ADVISES ON LUPIN'S DIVESTMENT OF KYOWA PHARMACEUTICAL
Leading global law firm Herbert Smith Freehills is advising Nanomi B.V., a subsidiary of Lupin Limited, on the sale of its entire stake in its Japanese …
Patent and Pharma Update, October 2019
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector In this issue we provide updates from the …
HERBERT SMITH FREEHILLS ADVISES STRIDES ON DISPOSAL OF AUSTRALIAN PHARMACEUTICAL BUSINESS
International law firm Herbert Smith Freehills has advised Strides Pharma Science Limited, an Indian listed pharmaceuticals company, on the AU$394 …
Patent and Pharma Update, July 2019
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector In this issue we report on the implementation …
Patent and Pharma Update, April 2019
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector This issue reports on the recent UK Supreme …
Just What The Doctor Ordered: The High Court Upholds The Award Methodology For The UK’s Largest Ever Procurement Of Medicines
The High Court has rejected a legal challenge alleging that NHS England had breached procurement law when setting the rules for a major procurement of …
Patent and Pharma Update, December 2018
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector This issue reports on several ground-breaking …
UPC latest news
Stay up to date with the Unified Patent Court (UPC) and unitary patent (UP) system.EPO issues guidance on achieving unitary patent status from day 1 of …
Draft Withdrawal Agreement Approved by UK Cabinet – IP and Marketing Authorisation Provisions Summarised
As has been widely reported, the Draft Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union …
Personalised Health and The Future of Pharma
Growing social and political pressures combined with disruptive technologies and scientific innovation are changing the way pharma companies do …
Patent and Pharma Update, October 2018
Key recent developments in the United Kingdom and Europe relating to patents and the pharmaceutical sector The CJEU has provided its preliminary ruling …
Showing 36 out of 59 results
View more